Latest Product Innovation News

Reliance Worldwide Corporation has agreed to an exclusivity period with Brookfield Capital Partners over a A$4.75 per share acquisition proposal, valuing the company at around A$4.1 billion. The deal includes a 30-day go-shop provision allowing alternative bids.

Iress Limited’s half year net profit after tax surged 85% to $32 million, driven by sharp cost cuts and margin expansion, even as total revenue fell nearly 17% following recent divestments.

The a2 Milk Company posted a 12.4% rise in FY26 revenue to NZ$1.975 billion, but net profit from continuing operations fell 5.8% amid supply chain disruptions in China. The company declared a $300 million special dividend and expects mid single-digit revenue growth in FY27.

Telstra reported a solid FY26 with EBITDAaL up 4% and cash EPS rising 14%, alongside increased capital expenditure and a new $1 billion share buyback. The company is advancing its digital infrastructure investments and AI capabilities while addressing a significant July network outage under regulatory scrutiny.

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Bell Financial Group surged to a $21.7 million half-year profit, more than doubling its net profit on stronger markets and the launch of its Bell Potter Private Wealth platform. The company also lifted its interim dividend by 67%, reflecting confidence in its diversified financial services model.

SEEK Limited delivered solid operational growth with record dividends in FY2026, yet posted a hefty net loss driven by a $284m impairment on its Chinese associate Zhaopin and a $201m loss from its Growth Fund.

AGL Energy reported a 575% surge in statutory profit to $756 million for FY26, driven by strategic divestments and improved asset flexibility, while declaring a fully franked 50 cents dividend and progressing its energy transition with 12 GW of renewable capacity targeted by 2035.

Elixinol Wellness (ASX: EXL) has posted a record quarterly revenue of A$4.3 million alongside a 45% gross margin, marking a clear shift from its US CBD origins to a diversified Australian wellness platform. Cost reductions and disciplined cash flow management underpin the company’s readiness to scale.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

Aura Consolidated Group delivers strong pro forma Q2 2026 results with 27% revenue growth and a 51% improvement in adjusted EBITDA following its acquisition of Qoria.

REA Group Ltd (ASX:REA) posted a robust FY26 with revenue up 7% to A$1.793 billion and core net profit rising 15% to A$682 million, supported by record audience engagement and strategic AI investments.